Therapeutic Drug Monitoring

TDM Introduction - Precision Dosing 101

• Therapeutic Drug Monitoring (TDM): Optimizing drug therapy by measuring drug concentrations in biological fluids.
• Goal: Maintain concentrations within a target therapeutic window to ensure efficacy & minimize toxicity.
• Crucial for drugs with:
  • Narrow Therapeutic Index (NTI)
  • Significant pharmacokinetic variability
  • Concentration-related therapeutic/toxic effects
• Relies on understanding PK/PD relationships.

⭐ TDM aims to individualize dosage regimens by maintaining plasma drug concentrations within a target therapeutic range.

Indications for TDM - Narrow Escape Artists

TDM is vital for "Narrow Escape Artists" - drugs demanding precise dosing. Key indications include:

⭐ TDM is crucial for drugs where clinical effect is difficult to monitor and there's a good correlation between drug concentration and effect/toxicity.

Pharmacokinetics in TDM - Drug's Body Journey

• LADME: Core processes (Liberation, Absorption, Distribution, Metabolism, Excretion).
• Key Parameters:
  • Bioavailability (F): Fraction of administered drug reaching systemic circulation.
  • Volume of Distribution ($V_d$): Apparent volume into which a drug distributes. $V_d = Dose / C_0$.
  • Clearance (CL): Volume of plasma cleared of drug per unit time. $CL = k \times V_d$.
  • Half-life ($t_{1/2}$): Time for drug concentration to decrease by half. $t_{1/2} = (0.693 \times V_d) / CL$.
• Steady State ($C_{ss}$): Achieved when rate of drug administration equals rate of elimination.
  • Formula: $C_{ss} = (Dose \times F) / (CL \times \tau)$, where $\tau$ is dosing interval.
• Therapeutic Window: Range between Minimum Effective Concentration (MEC) & Minimum Toxic Concentration (MTC).
• Sampling Times: Crucial for interpretation.
  • Trough level: Just before next dose (lowest concentration).
  • Peak level: After drug distribution (highest concentration).

⭐ Steady state concentration ($C_{ss}$) is usually achieved after 4-5 elimination half-lives of the drug.

oka

TDM Process - Sample, Test, Adjust

⭐ For most drugs, trough (pre-dose) concentrations are measured to assess therapeutic efficacy and minimize toxicity risk.

• Key Considerations:
  • Steady State: Achieved after 3-5 drug half-lives.
  • Sample Type: Serum or plasma typically used.
  • Assay Specificity & Precision: Crucial for reliable results.

Key Monitored Drugs - The TDM VIP List

High‑Yield Points - ⚡ Biggest Takeaways

• TDM optimizes dosing by maintaining drug concentrations within the therapeutic window, preventing toxicity.
• Essential for drugs with a narrow therapeutic index (e.g., Digoxin, Lithium, Phenytoin, Theophylline).
• Correct sample timing (often trough levels just before the next dose) is paramount for accurate interpretation.
• Monitoring is most reliable at steady state (typically after 4-5 half-lives of the drug).
• Patient factors like renal/hepatic function, adherence, and drug interactions significantly influence levels.
• Key drugs also include Aminoglycosides (e.g., Gentamicin, Amikacin) and Vancomycin.